Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Effect of cisplatin on cell cycle regulators]

K Nishio, N Saijo

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |February 1, 1994
    PubMed
    Summary

    Cisplatin (CDDP) halts cancer cell division at the G2 phase by inhibiting p34cdc2 dephosphorylation. This mechanism is key to cisplatin's anticancer effects, impacting cell-cycle regulation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Direct observation of the superallowed α-decay of <sup>104</sup>Te.

    Nature·2026
    Same author

    Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results.

    ESMO open·2023
    Same author

    A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR).

    ESMO open·2022
    Same author

    Open-label phase II study of the efficacy of nivolumab for cancer of unknown primary.

    Annals of oncology : official journal of the European Society for Medical Oncology·2021
    Same author

    Simultaneous Determination of Neutron-Induced Fission and Radiative Capture Cross Sections from Decay Probabilities Obtained with a Surrogate Reaction.

    Physical review letters·2020
    Same author

    Study of Quasielastic Barrier Distributions as a Step towards the Synthesis of Superheavy Elements with Hot Fusion Reactions.

    Physical review letters·2020

    Area of Science:

    • Cell Biology
    • Molecular Oncology

    Context:

    • Cisplatin (CDDP) is a widely used anticancer drug.
    • Understanding its precise mechanism of action on cell-cycle regulation is crucial for optimizing cancer therapy.

    Purpose:

    • To investigate how cisplatin (CDDP) affects cell-cycle regulators, specifically p34cdc2 protein kinase, in PC-9 human cancer cells.
    • To elucidate the role of p34cdc2 dephosphorylation in cisplatin-induced G2-phase arrest.

    Summary:

    • Cisplatin (CDDP) treatment of PC-9 cells, initiated in the G1 phase, resulted in arrest at the G2 phase.
    • CDDP inhibited the activation of p34cdc2 kinase, which normally peaks in G2 phase.
    • The study suggests that CDDP's growth-inhibiting properties are linked to its ability to inhibit p34cdc2 dephosphorylation, while cyclin A, B, and wee-1 kinase remain unaffected.

    Impact:

    • Provides insights into the molecular mechanisms underlying cisplatin's efficacy.
    • Identifies p34cdc2 dephosphorylation as a potential therapeutic target for enhancing anticancer drug activity.
    • Contributes to the development of novel strategies for overcoming drug resistance in cancer treatment.

    Related Experiment Videos